TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
ADD Accelerated Drug Development AB
Closing information (x1000 SEK)
| Closing information | 2023/06 | 2022/06 | 2021/06 |
| Turnover |
558
|
450 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
5
|
3 | |
| EBITDA |
5
|
3 | |
| Total assets |
4,494
|
3,942 | |
| Current assets |
2,015
|
1,464 | |
| Current liabilities |
3,882
|
3,430 | |
| Equity capital |
512
|
512 | |
| - share capital |
500
|
500 | |
| Employees (average) |
0
|
0
|
1 |
Financial ratios
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Solvency |
11.4%
|
13.0% | |
| Turnover per employee | 450 | ||
| Profit as a percentage of turnover |
0.9%
|
0.7% | |
| Return on assets (ROA) |
0.1%
|
0.1% | |
| Current ratio |
51.9%
|
42.7% | |
| Return on equity (ROE) |
1.0%
|
0.6% | |
| Change turnover |
108
|
135 | |
| Change turnover % |
14%
|
24%
|
43% |
| Chg. No. of employees |
0
|
-1
|
0 |
| Chg. No. of employees % |
-100%
|
0% |
Total value of public sale
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.